Expert Panel Asks Serum Institute To Tighten HPV Vaccine Trial Before Testing On Women Of Childbearing Age

Committee seeks stronger trial design, urging SII to sharpen objectives and raise scientific standards for proving CERVAVAC’s non-inferiority to Merck’s Gardasil